title: Structural domains in phospholemman: a possible role for the carboxyl terminus in channel inactivation.
abstract: Phospholemman (PLM) is a small (72-amino acid) transmembrane protein found in cardiac sarcolemma that is a major substrate for several protein kinases in vivo. Detailed structural data for PLM is lacking, but several studies have described an ion conductance that results from PLM expression in oocytes. Moreover, addition of purified PLM to lipid bilayers generates similar ion currents, suggesting that the PLM molecule itself might be sufficient for channel formation. To provide a framework for understanding the function of PLM, we investigated PLM topology and structure in sarcolemmal membrane vesicles and analyzed purified recombinant PLM. Immunoblot analyses with site-specific antibodies revealed that the extracellular segment (residues 1 to 17) exists in a protected configuration highly resistant to proteases, even in detergent solutions. The intracellular portion of the molecule (residues 38 to 72), in contrast, was highly susceptible to proteases. Trypsin treatment produced a limit peptide (residues 1 to 43), which showed little change in electrophoretic mobility in SDS gels and retained the ion-channel activity in lipid bilayers that is characteristic of the full-length protein. In addition, we found that conductance through PLM channels exhibited rapid inactivation during depolarizing ramps at voltages greater than +/- 50 mV, Channels formed by trypsinized PLM or recombinant PLM 1-43 exhibited dramatic reductions in voltage-dependent inactivations. Our data point to distinct domains within the PLM molecule that may correlate with functional properties of channel activity observed in oocytes and lipid bilayers.
authors.affiliation: Department of Medicine and the Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis 46201, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Chen
authors.forename: L R
authors.initials: LR
authors.lastname: Jones
authors.forename: J J
authors.initials: JJ
authors.lastname: O'Brian
authors.forename: J R
authors.initials: JR
authors.lastname: Moorman
authors.forename: S E
authors.initials: SE
authors.lastname: Cala
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D004285:Dogs; D010450:Endopeptidases / Q000378:metabolism; D007473:Ion Channels / Q000378:metabolism; D008051:Lipid Bilayers / Q000378:metabolism; D008565:Membrane Proteins / Q000737:chemistry* / Q000235:genetics / Q000502:physiology*; D008969:Molecular Sequence Data; D009206:Myocardium / Q000378:metabolism; D010446:Peptide Fragments / Q000502:physiology*; D010447:Peptide Hydrolases / Q000378:metabolism; D010750:Phosphoproteins / Q000737:chemistry* / Q000235:genetics / Q000502:physiology*; D011994:Recombinant Proteins; D012508:Sarcolemma / Q000378:metabolism; D013329:Structure-Activity Relationship; D014357:Trypsin / Q000494:pharmacology
chemical_list: D007473:Ion Channels; D008051:Lipid Bilayers; D008565:Membrane Proteins; D010446:Peptide Fragments; D010750:Phosphoproteins; D011994:Recombinant Proteins; C069141:phospholemman; D010450:Endopeptidases; D010447:Peptide Hydrolases; D014357:Trypsin